Delivery Order SPE2DB20D2014-SPE2DB25FC14W

Award Date 6/6/25
Potential Completion Date 6/9/25
Potential Value $10K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of WEGOVY 1.7 mg/0.75 ml pens to the Defense Logistics Agency (DLA). The contract, valued at $2,522.11, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 13, 2024 and is a firm fixed-price delivery order. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite Delivery...
This federal contract award is for the delivery of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML pharmaceutical products to the U.S. Defense Logistics Agency (DLA) Troop Support Medical. The $10,344.93 firm-fixed-price delivery order was awarded to prime contractor Amerisourcebergen Drug Corp, Corporate Office Division, and has an ultimate completion date of September 17, 2024. This award is not associated with a set-aside program. Amerisourcebergen is a major pharmaceutical distributor that has been awarded...
This federal contract award is for the delivery of WEGOVY 1.7 MG/0.75 ML PEN 0.75ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,097.08 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of July 18, 2024 and was not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The contract, valued at $1,673.41, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of July 17, 2023. The contract does not have a set-aside designation, indicating it...
This federal contract award is for the delivery of WEGOVY 0.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA). The contract, valued at $5,024.56, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 13, 2024, with a completion date of March 14, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML pharmaceutical products to the Defense Logistics Agency (DLA). The award, valued at $5,164.16, was made to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has a completion date of February 13, 2024 and is a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to...
The federal contract award is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $1,638.00 and is a firm fixed-price delivery order. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is not set-aside and has an ultimate completion date of May 23, 2025. Amerisourcebergen Drug Corp...
This federal contract award is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML pharmaceutical products. The contract was awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,970.65 firm fixed-price delivery order has a completion date of March 11, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award is for the delivery of WEGOVY 0.25 MG/0.5 ML PEN 0.5ML pharmaceutical products to the Defense Logistics Agency (DLA). The $1,228.50 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a completion date of February 27, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of WEGOVY 0.5 mg/0.5 ml pens to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,097.08, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB25FC14W
    Delivery Order

The federal contract award is for the delivery of WEGOVY 2.4 MG/0.75 ML PEN 0.75ML pharmaceutical products. The contract, valued at $10,419.96, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA), a defense agency. The contract is a Firm Fixed Price Delivery Order with a completion date of June 9, 2025. Amerisourcebergen Drug Corp is a for-profit organization that serves as a critical supplier of medical and pharmaceutical products to federal agencies, including the DLA. The contract is not set aside and is open to competition. Amerisourcebergen Drug Corp also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026.

Generated 9/5/25, 9:56 AM